217 related articles for article (PubMed ID: 16011840)
21. Transcriptional regulation of the tissue factor gene by progestins in human endometrial stromal cells.
Krikun G; Schatz F; Mackman N; Guller S; Lockwood CJ
J Clin Endocrinol Metab; 1998 Mar; 83(3):926-30. PubMed ID: 9506750
[TBL] [Abstract][Full Text] [Related]
22. The role of progestationally regulated stromal cell tissue factor and type-1 plasminogen activator inhibitor (PAI-1) in endometrial hemostasis and menstruation.
Lockwood CJ; Krikun G; Papp C; Toth-Pal E; Markiewicz L; Wang EY; Kerenyi T; Zhou X; Hausknecht V; Papp Z
Ann N Y Acad Sci; 1994 Sep; 734():57-79. PubMed ID: 7978955
[TBL] [Abstract][Full Text] [Related]
23. Tissue-selectivity: the mechanism of action of tibolone.
Kloosterboer HJ
Maturitas; 2004 Aug; 48 Suppl 1():S30-40. PubMed ID: 15337246
[TBL] [Abstract][Full Text] [Related]
24. Comparative effects of chlormadinone acetate and its 3alpha- and 3beta-hydroxy metabolites on progesterone, androgen and glucocorticoid receptors.
Schneider J; Kneip C; Jahnel U
Pharmacology; 2009; 84(2):74-81. PubMed ID: 19590256
[TBL] [Abstract][Full Text] [Related]
25. Levels of tibolone and estradiol and their nonsulfated and sulfated metabolites in serum, myometrium, and vagina of postmenopausal women following treatment for 21 days with tibolone, estradiol, or estradiol plus medroxyprogestrone acetate.
Verheul HA; Blok LJ; Burger CW; Hanifi-Moghaddam P; Kloosterboer HJ
Reprod Sci; 2007 Feb; 14(2):160-8. PubMed ID: 17636227
[TBL] [Abstract][Full Text] [Related]
26. Effect of tibolone and its metabolites on vascular endothelial growth factor isoforms 121 and 165 and thrombospondin-1 mRNA in Ishikawa cells.
Mirkin S; Mahony MC; Archer DF
Menopause; 2004; 11(1):82-8. PubMed ID: 14716187
[TBL] [Abstract][Full Text] [Related]
27. Regulation of synthesis of the transformation-induced protein, leukocyte plastin, by ovarian steroid hormones.
Leavitt J; Chen ZP; Lockwood CJ; Schatz F
Cancer Res; 1994 Jul; 54(13):3447-54. PubMed ID: 8012965
[TBL] [Abstract][Full Text] [Related]
28. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
[TBL] [Abstract][Full Text] [Related]
29. Receptor profiling and endocrine interactions of tibolone.
de Gooyer ME; Deckers GH; Schoonen WG; Verheul HA; Kloosterboer HJ
Steroids; 2003 Jan; 68(1):21-30. PubMed ID: 12475720
[TBL] [Abstract][Full Text] [Related]
30. Progestin regulation of plasminogen activator inhibitor type 1 in primary cultures of endometrial stromal and decidual cells.
Schatz F; Lockwood CJ
J Clin Endocrinol Metab; 1993 Sep; 77(3):621-5. PubMed ID: 8370684
[TBL] [Abstract][Full Text] [Related]
31. Histological and immunohistochemical evaluation of postmenopausal endometrium after 3 weeks of treatment with tibolone, estrogen only, or estrogen plus progestagen.
Klaassens AH; van Wijk FH; Hanifi-Moghaddam P; Sijmons B; Ewing PC; Ten Kate-Booij MJ; Kooi GS; Kloosterboer HJ; Blok LJ; Burger CW
Fertil Steril; 2006 Aug; 86(2):352-61. PubMed ID: 16828477
[TBL] [Abstract][Full Text] [Related]
32. Progestin-epidermal growth factor regulation of tissue factor expression during decidualization of human endometrial stromal cells.
Lockwood CJ; Krikun G; Runic R; Schwartz LB; Mesia AF; Schatz F
J Clin Endocrinol Metab; 2000 Jan; 85(1):297-301. PubMed ID: 10634402
[TBL] [Abstract][Full Text] [Related]
33. Estrogen and tibolone metabolite levels in blood and breast tissue of postmenopausal women recently diagnosed with early-stage breast cancer and treated with tibolone or placebo for 14 days.
Kloosterboer HJ; Löfgren L; von Schoulz E; von Schoultz B; Verheul HA
Reprod Sci; 2007 Feb; 14(2):151-9. PubMed ID: 17636226
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of oestrone sulphatase activity by tibolone and its metabolites.
Purohit A; Malini B; Hooymans C; Newman SP
Horm Metab Res; 2002 Jan; 34(1):1-6. PubMed ID: 11832993
[TBL] [Abstract][Full Text] [Related]
35. Testosterone inhibits matrix metalloproteinase-1 production in human endometrial stromal cells in vitro.
Ishikawa T; Harada T; Kubota T; Aso T
Reproduction; 2007 Jun; 133(6):1233-9. PubMed ID: 17636177
[TBL] [Abstract][Full Text] [Related]
36. Implications of decidualization-associated protease expression in implantation and menstruation.
Schatz F; Krikun G; Runic R; Wang EY; Hausknecht V; Lockwood CJ
Semin Reprod Endocrinol; 1999; 17(1):3-12. PubMed ID: 10406070
[TBL] [Abstract][Full Text] [Related]
37. Basal release of urokinase plasminogen activator, plasminogen activator inhibitor-1, and soluble plasminogen activator receptor from separated and cultured endometriotic and endometrial stromal and epithelial cells.
Bruse C; Guan Y; Carlberg M; Carlström K; Bergqvist A
Fertil Steril; 2005 Apr; 83 Suppl 1():1155-60. PubMed ID: 15831288
[TBL] [Abstract][Full Text] [Related]
38. Tibolone and its metabolites inhibit invasion of human mammary carcinoma cells in vitro.
Vanhoecke BW; Bracke ME; Kloosterboer HJ; Depypere HT
Maturitas; 2006 Jun; 54(3):229-37. PubMed ID: 16581209
[TBL] [Abstract][Full Text] [Related]
39. The nature of inhibition of steroid sulphatase activity by tibolone and its metabolites.
Raobaikady B; Day JM; Purohit A; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):229-37. PubMed ID: 15862970
[TBL] [Abstract][Full Text] [Related]
40. Tibolone and its metabolites induce antimitogenesis in human coronary artery smooth muscle cells: role of estrogen, progesterone, and androgen receptors.
Dubey RK; Gillespie DG; Grögli M; Kloosterboer HJ; Imthurn B
J Clin Endocrinol Metab; 2004 Feb; 89(2):852-9. PubMed ID: 14764805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
